Cargando…
Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma
Follicular lymphoma (FL) is the most common type of indolent B-cell lymphoma. Twenty years ago, FL was considered an indolent lymphoma with a long survival time but without a high rate of complete remission with chemotherapies. The use of rituximab has improved the response and survival of patients...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426075/ https://www.ncbi.nlm.nih.gov/pubmed/30906531 http://dx.doi.org/10.12688/f1000research.16686.1 |